Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04424030 · ClinicalTrials.gov registry record
International Consortium for Multimodality Phenotyping in Adults With Non-compaction
A clinical trial of Non-Compaction Cardiomyopathy, sponsored by Stanford University.
- Recruiting
- Registry status
- 600
- Enrollment target
- 5
- Study locations
NCT04424030 is a study of Non-Compaction Cardiomyopathy that is actively recruiting participants, run by Stanford University. The registered enrollment target is 600 participants. The trial reports 5 study locations across 4 states.
The verdict
NCT04424030, a study of Non-Compaction Cardiomyopathy, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- 600 participants
- Enrollment target
- 5
- Study locations
Study Summary
Non-compaction cardiomyopathy (NCCM) is a heterogeneous, poorly understood disorder characterized by a prominent inner layer of loose myocardial tissue, and associated with heart failure, stroke, severe rhythm irregularities and death. For a growing population diagnosed with NCCM there is a need for better risk stratification to appropriately allocate (or safely withhold) these impactful preventive measures. The goal of this international consortium is to improve care of patients with non-compaction cardiomyopathy. We hypothesize that comprehensive analysis of clinical, genetic, structural and functional information will improve risk stratification. In addition, we hypothesize that detailed structural analysis will allow for differentiation of pathological and benign patterns of non-compaction. In a large cohort of adult patients with suspected NCCM we will perform in-depth phenotyping, including clinical information, pedigree data, genetics, echocardiography and MRI, and follow patients for up to 3 years. We will apply machine-learning based analytics to develop predictive models and compare their performance to currently used models and treatment criteria. Secondly, in a subset of patients we will perform high-resolution cardiac CT for detailed structural characterization of the myocardial wall. We will investigate associations between myocardial structure and regional contractile function, as assessed by echo and MRI. The aim of this proposal is to identify a structural signature associated with pathological non-compaction and improve developed risk prediction models. Discovery of pathological structural signatures through innovative imaging techniques, in relation to myocardial contractility, will advance our understanding of NCCM.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Echocardiography
- DIAGNOSTIC_TEST Magnetic resonance imaging (MRI)
- DIAGNOSTIC_TEST Computed tomography (CT)
Study Locations (5)
Other
- Erasmus Medical Center - Rotterdam
- Seoul National University Hospital - Seoul
California
- Stanford University - Palo Alto
Ohio
- Cleveland Clinic Foundation - Cleveland
Pennsylvania
- University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2027-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04424030
The ClinicalTrials.gov registry entry for NCT04424030 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Compaction Cardiomyopathy appearing as the primary indexed condition, and to 3 interventions - of which Echocardiography is the first listed.
NCT04424030 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Other, California, Ohio.
Frequently Asked Questions
What is clinical trial NCT04424030 about?
NCT04424030 is a clinical study titled "International Consortium for Multimodality Phenotyping in Adults With Non-compaction". Non-compaction cardiomyopathy (NCCM) is a heterogeneous, poorly understood disorder characterized by a prominent inner layer of loose myocardial tissue, and associated with heart failure, stroke, severe rhythm irregularities and death. For a growing population diagnosed with NCCM there is a need for...
What is the current status of trial NCT04424030?
This trial is currently recruiting. The enrollment target is 600 participants. The study started on 2021-01-01. Estimated completion is 2027-04-01.
What conditions does trial NCT04424030 study?
This clinical trial studies the following conditions: Non-Compaction Cardiomyopathy.
What interventions are being tested in trial NCT04424030?
The interventions under investigation include: Echocardiography (DIAGNOSTIC_TEST), Magnetic resonance imaging (MRI) (DIAGNOSTIC_TEST), Computed tomography (CT) (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04424030?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04424030 being conducted?
This trial has 5 study locations across California, Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.